The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma

被引：0
|
作者：
Chen Xue
Xinyu Gu
Qingmiao Shi
Xiao Ma
Junjun Jia
Yuanshuai Su
Zhengyi Bao
Juan Lu
Lanjuan Li
机构：
[1] The First Affiliated Hospital,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis
[2] Zhejiang University School of Medicine,Department of Oncology, College of Clinical Medicine
[3] The First Affiliated Hospital,Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery
[4] Henan University of Science and Technology,undefined
[5] The First Affiliated Hospital,undefined
[6] Zhejiang University School of Medicine,undefined
来源：
Journal of Translational Medicine | / 22卷
关键词：
Hepatocellular carcinoma; Intratumor bacteria; Metabolites; Biomarker; Therapeutic targets;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
    Xue, Chen
    Gu, Xinyu
    Shi, Qingmiao
    Ma, Xiao
    Jia, Junjun
    Su, Yuanshuai
    Bao, Zhengyi
    Lu, Juan
    Li, Lanjuan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
    Chen Xue
    Junjun Jia
    Xinyu Gu
    Lin Zhou
    Juan Lu
    Qiuxian Zheng
    Yuanshuai Su
    Shusen Zheng
    Lanjuan Li
    Signal Transduction and Targeted Therapy, 7
  • [3] Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
    Xue, Chen
    Jia, Junjun
    Gu, Xinyu
    Zhou, Lin
    Lu, Juan
    Zheng, Qiuxian
    Su, Yuanshuai
    Zheng, Shusen
    Li, Lanjuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [4] Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
    Xu, Fei-Qi
    Dong, Meng-Meng
    Wang, Zhi-Fei
    Cao, Li-Dong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] INTRATUMORAL IMMUNE MODULATION FOR HEPATOCELLULAR CARCINOMA
    Li, Ling
    Yu, Hongzhe
    Qian, Hongtao
    Weng, Justin
    Green, Jordan J.
    Selaru, Florin M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1739 - S1740
  • [6] Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
    Lin, Huangpeng
    Ma, Zexian
    Li, Jin
    Zhu, Heping
    Huang, Xuefeng
    Chen, Huimin
    Tu, Liang
    Lian, Yifan
    Su, Yongjie
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [7] Radiofrequency ablation for hepatocellular carcinoma and intratumoral pressure
    Kowamoto, Chiaki
    Yamauchi, Atsushi
    Baba, Yoko
    Yakabi, Koji
    HEPATOLOGY, 2007, 46 (04) : 421A - 421A
  • [8] Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
    Song, Yagang
    Tian, Shuo
    Li, Zhanzhan
    Miao, Jinxin
    Wu, Mingming
    Xu, Tingli
    Wu, Xiangxiang
    Qiao, Jingyi
    Zhang, Xialei
    Zhao, Hui
    Kang, Le
    Cao, Lihua
    Zhu, Pingsheng
    Miao, Mingsan
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2025, 12 : 59 - 76
  • [9] The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
    Huang, Jian-Hang
    Wang, Jie
    Chai, Xiao-Qiang
    Li, Zhong-Chen
    Jiang, Ying-Hua
    Li, Jun
    Liu, Xing
    Fan, Jia
    Cai, Jia-Bin
    Liu, Feng
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [10] A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
    Cauchy, Francois
    Belghiti, Jacques
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 19 - 27
12345